International Conference on Malignant Lymphoma
E1312970
UNEXPLORED
The International Conference on Malignant Lymphoma is a major global scientific meeting that brings together experts to present and discuss advances in the research, diagnosis, and treatment of lymphoid cancers.
All labels observed (1)
| Label | Occurrences |
|---|---|
| International Conference on Malignant Lymphoma canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T18213096 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: International Conference on Malignant Lymphoma Context triple: [Lugano classification, endorsedBy, International Conference on Malignant Lymphoma]
-
A.
Leukemia and Lymphoma Research
Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
-
B.
Hodgkin
Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
-
C.
Hodgkin lymphoma
Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
-
D.
non-Hodgkin lymphoma
Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
-
E.
American Society of Hematology
The American Society of Hematology is a leading professional organization dedicated to advancing the understanding, diagnosis, treatment, and prevention of blood-related diseases through research, education, and advocacy.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: International Conference on Malignant Lymphoma Target entity description: The International Conference on Malignant Lymphoma is a major global scientific meeting that brings together experts to present and discuss advances in the research, diagnosis, and treatment of lymphoid cancers.
-
A.
Leukemia and Lymphoma Research
Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
-
B.
Hodgkin
Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
-
C.
Hodgkin lymphoma
Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
-
D.
non-Hodgkin lymphoma
Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
-
E.
American Society of Hematology
The American Society of Hematology is a leading professional organization dedicated to advancing the understanding, diagnosis, treatment, and prevention of blood-related diseases through research, education, and advocacy.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.